| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/11/1997 | US5601816 Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production of same |
| 02/11/1997 | CA2055052C Low temperature inactive baker's yeast |
| 02/11/1997 | CA1338902C Plant cells resistant to herbicidal glutamine synthetase inhibitors |
| 02/11/1997 | CA1338901C Recombinant dna sequences, vectors containing them and methods for the use thereof |
| 02/11/1997 | CA1338900C Escherichia coli plasmid vector with lipoprotein promoter and modified shine-dalgarno sequence |
| 02/06/1997 | WO1997004317A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 02/06/1997 | WO1997004315A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004132A1 Detection of hydrophobic amplification products by extraction into an organic phase |
| 02/06/1997 | WO1997004130A1 A method and system for sequencing genomes |
| 02/06/1997 | WO1997004129A1 Method for nucleic acid sequencing |
| 02/06/1997 | WO1997004123A1 Collagen compound production in plants |
| 02/06/1997 | WO1997004122A1 Production of secreted foreign polypeptides in plant cell culture |
| 02/06/1997 | WO1997004119A1 Viral vectors and line for gene therapy |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004117A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | WO1997004116A1 Inhibition of cell respiration and production of male sterile plants |
| 02/06/1997 | WO1997004115A2 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 02/06/1997 | WO1997004114A2 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
| 02/06/1997 | WO1997004113A2 Inhibition of gene expression |
| 02/06/1997 | WO1997004112A2 Inhibition of gene expression |
| 02/06/1997 | WO1997004111A1 RecA-ASSISTED CLONING OF DNA |
| 02/06/1997 | WO1997004110A1 Methods for increasing protein expression |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004108A1 Leucine aminopeptidases produced recombinantly from aspergillus soyae |
| 02/06/1997 | WO1997004107A1 Process for the modification of toxic and/or off-flavoured compounds |
| 02/06/1997 | WO1997004106A2 New saccharomyces cerevisiae pectinase sequences and heterologous expression systems derived therefrom |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004104A2 Tumor type ii hexokinase transcription regulatory regions |
| 02/06/1997 | WO1997004103A2 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
| 02/06/1997 | WO1997004102A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
| 02/06/1997 | WO1997004101A2 Enzyme suitable for oxidising cyclitols and their derivatives |
| 02/06/1997 | WO1997004100A2 L-ascorbic acid synthesis by l-galactonatoxidoreductase |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004098A2 MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004094A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004091A1 Novel receptor ligands and genetic sequences encoding same |
| 02/06/1997 | WO1997004090A1 SEQUENCE AND EXPRESSION OF Sox-18 |
| 02/06/1997 | WO1997004089A2 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004088A1 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004087A1 Ribozymes for the selective inhibition of expression by mhc allele genes, and drugs containing such ribozymes |
| 02/06/1997 | WO1997004084A1 Enzymes and microorganisms having amidase activity for hydrolysing polyamides |
| 02/06/1997 | WO1997004083A1 Enzymes and micro-organisms with amidase activity which hydrolyse polyamides |
| 02/06/1997 | WO1997004079A1 A modified enzyme with lipolytic activity |
| 02/06/1997 | WO1997004078A1 A modified enzyme with lipolytic activity |
| 02/06/1997 | WO1997004077A1 Screening methods for enzymes and enzyme kits |
| 02/06/1997 | WO1997004076A1 Synthetic hpv11 virus-like particles |
| 02/06/1997 | WO1997004008A1 Anti-fungal peptides |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003999A1 Mutant s182 genes |
| 02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
| 02/06/1997 | WO1997003997A1 Anti-viral guanosine-rich oligonucleotides |
| 02/06/1997 | WO1997003939A1 Novel amide-based cationic lipids |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 02/06/1997 | WO1997003574A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 02/06/1997 | WO1997003555A1 Transgenic animal model of osteopenia |
| 02/06/1997 | WO1996040926A3 Detection of cryptosporidium parvum |
| 02/06/1997 | WO1996040924A3 Cotton fiber transcriptional factors |
| 02/06/1997 | WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 02/06/1997 | WO1996039501A3 Oligonucleotides specific for human papillomavirus |
| 02/06/1997 | WO1996037620A3 Process for obtaining acyloins, pyruvate decarboxylases suitable therefor and their production and dna sequences of the pdc gene coding them |
| 02/06/1997 | DE19528544A1 cDNA-Sequenz und daraus abgeleitete Aminosäuresequenz des Vorläuferproteins von humanem GCAP II/Uroguanylin sowie Aminosäuresequenz des im humanen Blut zirkulierenden Fragmentes cDNA sequence and deduced amino acid sequence of the precursor protein of human GCAP II / uroguanylin and amino acid sequence of the human blood circulating in the fragment |
| 02/06/1997 | DE19528029A1 Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung Magnetic polymer particles based on polyvinyl alcohol, processes for their preparation and use |
| 02/06/1997 | CA2227882A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | CA2227867A1 Anti-viral guanosine-rich oligonucleotides |
| 02/06/1997 | CA2227554A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | CA2227537A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227413A1 Reca-assisted cloning of dna |
| 02/06/1997 | CA2227373A1 Novel amide-based cationic lipids |
| 02/06/1997 | CA2227339A1 Synthetic hpv11 virus-like particles |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227292A1 Anti-fungal peptides |
| 02/06/1997 | CA2227277A1 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227196A1 Process for the modification of toxic and/or off-flavoured compounds |
| 02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226994A1 Inhibition of gene expression |
| 02/06/1997 | CA2226926A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2226832A1 Inhibition of gene expression |
| 02/06/1997 | CA2226625A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
| 02/06/1997 | CA2226545A1 Leucine aminopeptidases produced recombinantly from aspergillus soyae |
| 02/06/1997 | CA2225481A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 02/06/1997 | CA2224736A1 Inhibition of cell respiration and production of male sterile plants |
| 02/06/1997 | CA2224289A1 New protein hmw human mp52s |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |